What is heroine and brown sugar
heroin brown sugar drug pharmacology effects addiction
| Form | Appearance | Common Route |
|---|---|---|
| No. 4 (pure) | White powder | Intravenous injection |
| No. 3 (brown sugar) | Brown/tan powder | Smoked, snorted |
| Black tar heroin | Dark, sticky | Injection (subcutaneous/IV) |
| Treatment | Mechanism |
|---|---|
| Methadone (oral) | Long-acting mu-agonist; reduces craving and withdrawal |
| Buprenorphine/Suboxone | Partial mu-agonist; ceiling effect limits overdose risk |
| Naltrexone | Opioid antagonist; blocks euphoric effects |
| Behavioral therapies | Cognitive-behavioral therapy, contingency management |
| Injectable heroin (supervised) | Used in some countries for treatment-resistant cases |
Acetylation of morphine
acetylation of morphine to heroin diacetylmorphine chemistry mechanism
morphine heroin diacetylmorphine chemical structure acetylation

Summary : This image displays the chemical structure of a complex organic molecule, specifically morphine, on a blue hexagonal patterned background. chemical structure illustration: # Main Structure : • The molecule consists of five fused rings, including aromatic and non-aromatic rings. • Functional groups present: two hydroxyl groups (–OH), one ketone (C=O), and one tertiary amine (N–CH₃). • Stereochemistry is indicated with solid and dashed wedges for hydrogen and hydroxyl groups. • The nitrogen atom is bonded to a methyl group (–CH₃). • The structure is drawn in a skeletal formula style, with carbon atoms implied at vertices and hydrogen atoms shown only where necessary for clarity. # Labels & Notation : • Atoms labeled: HO (hydroxyl), H (hydrogen), O (oxygen), N (nitrogen), CH₃ (methyl). • Stereochemistry: solid wedges (out of plane), dashed wedges (into plane). • No explicit atom numbering or additional annotation. # Design & Background : • Molecule is rendered in light teal/green lines. • Background is a blue gradient with a subtle hexagonal pattern. • No axis, scale, or legend present. # Spatial Relationships : • The molecule is centered, with a partial structure visible on the left edge, suggesting a cropped or extended illustration. • The main focus is on the morphine molecule. # Analysis : • The image is a clear, stylized depiction of the morphine molecule, highlighting its key functional groups and stereochemistry. • The background and color scheme are chosen for visual appeal, not for data presentation. • No quantitative or comparative data is present; the image serves as a chemical illustration.

This diagnostic image displays four Ultra-High-Performance Liquid Chromatography (UHPLC) chromatograms stacked vertically, used for the chemical profiling and forensic analysis of illicit drug samples. Each panel represents a different UV detection wavelength: 251 nm, 245 nm, 215 nm, and 210 nm. The y-axis measures absorbance units (AU), while the x-axis represents retention time in minutes (0 to 20 minutes). The visual demonstrates the separation and identification of multiple compounds within a Southwest Asian heroin sample. Key labeled peaks correspond to morphine (b), acetaminophen (d), codeine (e), caffeine (f), O3-monoacetylmorphine (h), O6-monoacetylmorphine (i), lidocaine (j), acetylcodeine (k), heroin (l), papaverine (n), noscapine (o), and methorphan (r). The varying peak heights across different wavelengths illustrate the specific UV absorbance characteristics of each component. This comparative visualization is essential for forensic toxicology, allowing for the identification of primary drugs and common adulterants or impurities, which aids in determining the geographical origin and composition of seized substances.
![Summary : This flowchart illustrates the metabolic pathways of several opioids, showing how codeine, morphine, heroin, hydrocodone, hydromorphone, oxycodone, and oxymorphone are interconverted, including minor metabolic routes and key intermediates.
flowchart:
# Nodes :
• Codeine (rectangle)
• Morphine (rectangle)
• 6-MAM (rectangle) [abbreviation for 6-monoacetylmorphine]
• Heroin (rectangle)
• Hydrocodone (rectangle)
• Hydromorphone (rectangle)
• Oxycodone (rectangle)
• Oxymorphone (rectangle)
# Connectors :
• Codeine → Morphine (rightward arrow)
• Codeine → Hydrocodone (downward arrow, labeled "<15%")
• Morphine → Hydromorphone (downward arrow, labeled "<5%")
• Morphine ← 6-MAM (leftward arrow)
• 6-MAM ← Heroin (leftward arrow)
• Hydrocodone → Hydromorphone (rightward arrow)
• Oxycodone → Oxymorphone (rightward arrow)
# Layout :
• Top row (left to right): Codeine → Morphine ← 6-MAM ← Heroin
• Bottom row (left to right): Hydrocodone → Hydromorphone; Oxycodone → Oxymorphone
• Vertical arrows connect Codeine to Hydrocodone and Morphine to Hydromorphone.
• All nodes are rectangles with black arrows indicating direction of metabolic conversion.
• Minor metabolic routes are indicated by percentage labels on arrows.
# Analysis :
• The chart shows that codeine and morphine are central to opioid metabolism, with codeine converting to morphine and also to hydrocodone (<15%), while morphine converts to hydromorphone (<5%).
• Heroin is metabolized to 6-MAM, which then becomes morphine.
• Hydrocodone and oxycodone are metabolized to hydromorphone and oxymorphone, respectively.
• The flowchart highlights both major and minor metabolic pathways, with percentage values indicating the relative contribution of minor routes.](/_next/image?url=https%3A%2F%2Fcdn.orris.care%2Fcdss_images%2FGLGCA_1971996_1763332212296_0295e6ed-5aba-4fc1-9c69-4dea36c04e7d.png&w=3840&q=75)
Summary : This flowchart illustrates the metabolic pathways of several opioids, showing how codeine, morphine, heroin, hydrocodone, hydromorphone, oxycodone, and oxymorphone are interconverted, including minor metabolic routes and key intermediates. flowchart: # Nodes : • Codeine (rectangle) • Morphine (rectangle) • 6-MAM (rectangle) [abbreviation for 6-monoacetylmorphine] • Heroin (rectangle) • Hydrocodone (rectangle) • Hydromorphone (rectangle) • Oxycodone (rectangle) • Oxymorphone (rectangle) # Connectors : • Codeine → Morphine (rightward arrow) • Codeine → Hydrocodone (downward arrow, labeled "<15%") • Morphine → Hydromorphone (downward arrow, labeled "<5%") • Morphine ← 6-MAM (leftward arrow) • 6-MAM ← Heroin (leftward arrow) • Hydrocodone → Hydromorphone (rightward arrow) • Oxycodone → Oxymorphone (rightward arrow) # Layout : • Top row (left to right): Codeine → Morphine ← 6-MAM ← Heroin • Bottom row (left to right): Hydrocodone → Hydromorphone; Oxycodone → Oxymorphone • Vertical arrows connect Codeine to Hydrocodone and Morphine to Hydromorphone. • All nodes are rectangles with black arrows indicating direction of metabolic conversion. • Minor metabolic routes are indicated by percentage labels on arrows. # Analysis : • The chart shows that codeine and morphine are central to opioid metabolism, with codeine converting to morphine and also to hydrocodone (<15%), while morphine converts to hydromorphone (<5%). • Heroin is metabolized to 6-MAM, which then becomes morphine. • Hydrocodone and oxycodone are metabolized to hydromorphone and oxymorphone, respectively. • The flowchart highlights both major and minor metabolic pathways, with percentage values indicating the relative contribution of minor routes.
Morphine + Excess Acetic Anhydride (CH₃CO)₂O → 3,6-Diacetylmorphine (Heroin) + 2 Acetic Acid
| Property | Morphine | Heroin (3,6-Diacetylmorphine) |
|---|---|---|
| Molecular formula | C₁₇H₁₉NO₃ | C₂₁H₂₃NO₅ |
| Molecular weight | 285.3 g/mol | 369.4 g/mol |
| -OH at C-3 | Free phenolic -OH | Acetylated (-OCOCH₃) |
| -OH at C-6 | Free alcoholic -OH | Acetylated (-OCOCH₃) |
| Lipid solubility | Low | High (2-3× morphine) |

"Methylation of the phenolic hydroxyl at position 3, as in codeine, or acetylation of this hydroxyl, as in heroin, drastically reduces binding to the mu-opioid receptor; these compounds are converted in vivo to morphine and 6-acetylmorphine, respectively, to afford analgesia."

| Step | Reaction | Enzyme | Notes |
|---|---|---|---|
| Step 1 | Heroin → 6-MAM | Plasma/tissue esterases | Very rapid; the 3-acetyl group is removed first |
| Step 2 | 6-MAM → Morphine | Brain/plasma esterases | Active intermediate; also binds mu-receptors |
| Step 3 | Morphine → Morphine-6-glucuronide | Liver UGT enzymes | Potent active metabolite |

| Aspect | Key Point |
|---|---|
| Reaction type | Esterification (O-acetylation) of two -OH groups |
| Reagent | Acetic anhydride (excess) or acetyl chloride |
| Product | 3,6-Diacetylmorphine (heroin) |
| Effect on lipophilicity | Greatly increased → faster BBB penetration |
| Effect on receptor binding | Reduced directly, but it is a prodrug |
| Active metabolite | 6-MAM, then morphine |
| Forensic marker | 6-MAM is unique proof of heroin use |